Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Motor Activity 1Insulin Resistance 1Body Weight 1

Interventions

Exercise 9Resistance Training 6Metformin 3Fitness Trackers 2secukinumab 1YES1 protein, human 1Wearable Electronic Devices 1Vincristine 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Standard of Care 1Platelet Transfusion 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Nutrition Assessment 1Methods 1Melphalan 1Jogging 1High-Intensity Interval Training 1Heparin, Low-Molecular-Weight 1Green Or 1Etoposide 1Erythrocyte Transfusion 1Epoetin Alfa 1Dyrk Kinases 1Doxorubicin 1Diet Therapy 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Motor Activity × Caloric Restriction × Clear all
NCT01482286 2022-03-15

PULSE

Pennington Biomedical Research Center

Phase 3 Terminated
32 enrolled 10 charts

Body Weight, Insulin Resistance, Motor Activity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡